Journal of Thai Stroke Society

Effects of Telerehabilitation on Upper Limb Function Activities of Patients with Chronic Stroke

Wed, 10 Apr 2024 00:00:00 +0700

This study examined the impact of telerehabilitation on upper limb functional activities (ULFA) in individuals with chronic stroke. Ten participants underwent the telerehabilitation program consisting of a 70-minute session, five times a week for four weeks. The program included a combination of strength training and task-oriented training (TOT). ULFA, grip strength, upper limb motor impairments, muscle tone and quality of life were assessed by the Streamlined Wolf Motor Function Test-Chronic (SWMFT-C), Grip strength dynamometer, Fugl-Meyer assessment of Upper extremities (FMA-UE), Modified Ashworth Scale and Stroke Impact Scale (SIS), respectively. The findings revealed statistically significant improvements (p<0.05) in SWMFT-C, grip strength, FMA-UE, and SIS scores across the strength, hand function, and percentage of recovery domains following the training program. Video-based telerehabilitation, incorporating both strength training and TOT, notably enhances ULFA and contributes to an improved quality of life for chronic stroke patients.

Message from President of Thai Stroke Society

เจษฎา อุดมมงคล — Wed, 10 Apr 2024 00:00:00 +0700

Editorial

นภาศรี ชัยสินอนันต์กุล — Wed, 10 Apr 2024 00:00:00 +0700

Stroke news

รัชยุทธ ธนปิยชัยกุล — Wed, 10 Apr 2024 00:00:00 +0700

Vascular contributions to cognitive impairment and dementia

Pornpatr Dharmasaroja — Wed, 10 Apr 2024 00:00:00 +0700

Vascular contributions to cognitive impairment and dementia is used to describe the role of a range of vascular risk and vascular lesions on cognition. Mid-life exposure (45-64 years) to hypertension, smoking, diabetes mellitus has greater impact on dementia risk than similar vascular risk factors in late-life (>65 years). The combined risk score is stronger predictor of cognitive decline than independent risk factors. After a stroke, approximate 30% of patients develop vascular dementia. Cognitive assessment should be performed at 3 months or beyond in those suspected cognitive decline, because early cognitive improvement has been found after acute stroke. For primary prevention, controlling some vascular risk factors during mid-life, such as hypertension has been shown to lower risk of mild cognitive impairment.

The current strategic management of asymptomatic carotid stenosis

Songkram Chotik-anuchit — Wed, 10 Apr 2024 00:00:00 +0700

Asymptomatic carotid stenosis has been enormously debated, especially in the aspect of ischemic neurological prevention. The better efficacy of antiplatelets and lipid lowering agents may be enough for prevention of stroke. Patient with high risk plaque have the greater risk of stroke than usual. The characters of high risk plaque such as rapidly progressive stenosis, larger plaque area, large lipid core, thin fibrous cap and the evidence of distal embolization should be elucidated in all patient with carotid stenosis
Carotid endarterectomy (CEA) or carotid stenting (CAS) are currently suitable treatment in asymptomatic carotid stenosis of >60-70%. Although, the CEA had the lower risk of perioperative complications, but the higher risk of postoperative myocardial infarction. Therefore, the CAS may be alternative treatment especially in the patient who had high risk of perioperative complication from CEA.
Despite of the many issues concerned for strategic planning of stroke prevention. Comprehensive discussion between physician and patient are also the crucial complementary strategy for stroke prevention therapy.

COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia Leading to Stroke: An Extremely Rare but Possible Condition

Mubarak Muhammad, Shih Keng Loong, Sazaly AbuBakar — Wed, 10 Apr 2024 00:00:00 +0700

Coronavirus disease 2019 (COVID-19) vaccines remain the safest and most effective strategy against the COVID-19 pandemic. However, clinicians must be aware of any adverse events that might arise as a peculiar side effect in certain individuals. One of such extremely rare side effect that needs to be routinely integrated into the clinical decision-making arise from vector based COVID-19 vaccines that result in vaccine-induced thrombotic thrombocytopenia (VITT) and consequently stroke. Understanding any evolving information that relates with COVID-19 is critical to its successful containment and control. As such, unraveling the mechanism of VITT leading to stroke as well as its relevant clinical information is essential towards its successful integration into clinical guidelines. This short communication was therefore aimed at focusing on proposed mechanism through which stroke evolved from vaccine-induced thrombotic thrombocytopenia and its relevant clinical information for clinical practice. This study stresses the importance of being vigilant to the development of vaccine-induced thrombotic thrombocytopenia and stroke especially from the viewpoint of clinicians and other health care personnel. The phenomenon of VITT leading to stroke was also recommended for inclusion as a standard operation procedure in the standard clinical guidelines for the management of acute ischemic stroke.

Public Relations

สุรีรัตน์ สุวัชรังกูร — Wed, 10 Apr 2024 00:00:00 +0700